Navigation Links
FDA Advisers: Newer Forms of the 'Pill' Need Revised Warning Labels
Date:12/10/2011

By Steven Reinberg
HealthDay Reporter

THURSDAY, Dec. 8 (HealthDay News) -- U.S. health advisers recommended Thursday that several newer forms of oral contraceptives carry revised labels warning about an increased risk of potentially fatal blood clots.

The U.S. Food and Drug Administration advisers voted 21-5 in favor of the new labels for oral contraceptives such as Bayer's Yaz or Yasmin. Both contain a newer type of man-made progestin hormone called drospirenone, which could increase the chances of dangerous clots in the legs or lungs, compared to older forms of oral contraceptives. The newer contraceptives have been successfully marketed on the premise that they have fewer of the unwanted side effects of older hormone pills such as bloating, mood swings and acne.

"Clearly, the wording is inadequate and incomplete," said Dr. Richard Bockman, of New York's Hospital for Special Surgery, the Associated Press reported. "Adverse events have to be made graphic so physicians and patients are aware of the consequences."

Earlier Thursday, the panel members voted 15 to 11 that the newer contraceptives, which gained initial FDA approval in 2001, are a viable method of birth control, and that the benefits of preventing pregnancy outweigh the health risks.

While the FDA isn't obligated to follow the recommendations of its advisory panels, it usually does so.

Several doctors said in advance of the hearing that the potential increased risk of clots is not great, but should not be dismissed, either.

"It's a low risk but the risk exists," said Dr. Tara Narula, a cardiologist at Lenox Hill Hospital in New York City. "The idea of the FDA looking at this and potentially increasing the warning has no downside. If anything, it increases awareness and that can only be a good thing."

Women who smoke or have a history of blood clots should not be taking oral contraceptives, she said.

Narula add
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Newer cornea transplant surgery shows short- and long-term promise
2. Newer Blood Test Predicts Diabetes, Heart Disease
3. Newer Genetic Test for Autism More Effective
4. Newer Blood Thinner Beats Plavix for Bypass Patients
5. Newer Genetic Info Adds Little to Predicting Breast Cancer
6. In infant heart surgery, newer technique yields better survival in first year of life
7. Newer Drugs Beat Gleevec in Head-to-Head Trials
8. Decrease in suicide not linked to newer antidepressants
9. Newer, more intense chemotherapy with less radiation not more effective against Hodgkins lymphoma
10. Newer Drug May Help Prevent Fracture in Men With Prostate Cancer
11. Research shows rapid adoption of newer, more expensive prostate cancer treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Advisers: Newer Forms of the 'Pill' Need Revised Warning Labels 
(Date:8/31/2015)... ... August 31, 2015 , ... ... at the 16th Innovations in Healthcare(SM) Awards Event , on October 21, ... (ABL) Organization , recognizes innovative organizations and individuals who are dramatically reducing the ...
(Date:8/31/2015)... , ... August 31, 2015 , ... The dental implant ... according the American Academy of Implant Dentistry. (See Press Room ) More than ... require an implant procedure. With the increasing demand for dental implants, the National Association ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Three Bakers Gluten ... and retailers with even more relevant and easy-to-find information on their offering of gluten-free ... website has always been an important way for us to share information about our ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad Phil, ... ribbon-cutting ceremony on Aug. 26, generously hosted by the Collinsville Chamber of Commerce, ... AdvantaClean’s National Call Center and website since Aug. 17. , The Greens have ...
(Date:8/31/2015)... ... 2015 , ... Finnleo is pleased to announce another in a ... of extensive engineering and design of our newest sauna model, the Terrace combines high ... offered at a very attractive price-point. , Before outdoor saunas were a dream ...
Breaking Medicine News(10 mins):Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 2Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 4Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 5Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 6Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 7Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 8Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:Say “Hello” to the Brand New Finnleo Terrace Outdoor Saunas 2
... team up to make food fun,for those with diabetes, ... the daily decisions they make about food can have ... (ADA), together,with The HealthCentral Network,s FoodFit.com, launched Diabetes Foodsmart,today, ... to food for those,with diabetes., Based on the ...
... with 20 percent of all lung malignancies, scientists say ... appear to work together are associated with 20 percent of ... lung development, researchers report. , Understanding how these genes mesh ... according to the report in this week,s issue of the ...
... IRVINE, Calif., Oct. 9 Spectrum,Pharmaceuticals, Inc., (Nasdaq: ... of the Company on Wednesday, October 10, 2007, at ... at the Palace Hotel in San,Francisco, California. Spectrum,s presentation ... live webcast of Spectrum,s presentation will be available at, ...
... Two of the three scientists receiving the 2007 Nobel Prize ... Society early in their careers, bringing to 42 the number ... grantees Mario R. Capecchi, Ph.D. of the University of Utah ... are co-winners along with Sir Martin J. Evans of Cardiff ...
... Oct. 9 In light of last week,s,controversy ... seafood for,pregnant women and the announcement from private ... least 12 ounces of fish,and seafood a week, ... in the natural products sector, suggests that private ...
... Roaming Across ... Campuses in North Carolina, RESTON, Virginia, October 9 ... (RTLS), today announced,that it has been selected as the RTLS vendor ... system in the,United States. CHS is using the Ekahau RTLS solution ...
Cached Medicine News:Health News:Healthy Living Made Easy with New Diabetes Foodsmart e-Newsletter 2Health News:Healthy Living Made Easy with New Diabetes Foodsmart e-Newsletter 3Health News:3 New Lung Cancer Genes Identified 2Health News:Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum 2Health News:Purified Fish Oil Concentrates Offer Solution to Current Seafood Controversy for Pregnant and Breastfeeding Women! 2Health News:Carolinas HealthCare Selects Ekahau for One of Nation's Largest Healthcare System RTLS Deployments 2Health News:Carolinas HealthCare Selects Ekahau for One of Nation's Largest Healthcare System RTLS Deployments 3Health News:Carolinas HealthCare Selects Ekahau for One of Nation's Largest Healthcare System RTLS Deployments 4
(Date:8/31/2015)... -- Thousands of people will peacefully demonstrate their frustration ... epidemic at dozens of rallies across the country today. ... the United States has experienced skyrocketing rates ... heroin, yet the President has never once spoken publicly ... to President Obama , rally organizers compared his failure ...
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced a ... United States and Canada , ... The deal, worth up to $8.5 million over the next ... clinical validation and regulatory approval of Daktari,s HCV test. ... point-of-care instrument that can detect low levels of virus directly ...
(Date:8/31/2015)... , Aug. 31, 2015 With increasing ... is experiencing a rise in active partnerships. The ... underdeveloped nations to quantitate CD4 cell markers in ... - http://photos.prnewswire.com/prnh/20150831/262206LOGO New ... Global Flow Cytometry Market ( http://www.frost.com/nf0e ), finds ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4
... ViroPharma Incorporated (Nasdaq: VPHM ) today ... Centralized Marketing Authorization for Cinryze® (C1 inhibitor [human]) ... for routine prevention, pre-procedure prevention and acute treatment ... self administration option for appropriately trained patients included ...
... Texas, June 15, 2011 Two clinical trial studies authored by ... United Network of US Oncology have been selected to be ... July 29-30 in Miami and August 5-6 in Seattle. ... its 47th Annual Meeting June 3-7 at McCormick Place in Chicago. ...
Cached Medicine Technology:ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE) 2ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE) 3ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE) 4ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE) 5ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE) 6Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians 2Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians 3Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians 4
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The electrically active helix of CapSureFix Novus lead is designed to extend easily for active fixation and retract for venous passage....
Steroid eluting pacemaker leads...
... family of temporary sensing and pacing leads. ... in temporary pacing leads and improved upon ... use and less traumatic to heart tissue. ... Pacing Lead is designed for temporary atrial ...
Medicine Products: